Skip to main content

A Phase III Study of 131I Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Hematology-Oncology

Awarded By

Children's Hospital of Philadelphia

Start Date

June 8, 2020

End Date

April 1, 2022
 

Administered By

Pediatrics, Hematology-Oncology

Awarded By

Children's Hospital of Philadelphia

Start Date

June 8, 2020

End Date

April 1, 2022